Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

240 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Multiparametric MRI enables for differentiation of different degrees of malignancy in two murine models of breast cancer.
Gerwing M, Hoffmann E, Kronenberg K, Hansen U, Masthoff M, Helfen A, Geyer C, Wachsmuth L, Höltke C, Maus B, Hoerr V, Krähling T, Hiddeßen L, Heindel W, Karst U, Kimm MA, Schinner R, Eisenblätter M, Faber C, Wildgruber M. Gerwing M, et al. Among authors: wildgruber m. Front Oncol. 2022 Nov 2;12:1000036. doi: 10.3389/fonc.2022.1000036. eCollection 2022. Front Oncol. 2022. PMID: 36408159 Free PMC article.
Early monocyte response following local ablation in hepatocellular carcinoma.
Kimm MA, Kästle S, Stechele MMR, Öcal E, Richter L, Ümütlü MR, Schinner R, Öcal O, Salvermoser L, Alunni-Fabbroni M, Seidensticker M, Goldberg SN, Ricke J, Wildgruber M. Kimm MA, et al. Among authors: wildgruber m. Front Oncol. 2022 Oct 24;12:959987. doi: 10.3389/fonc.2022.959987. eCollection 2022. Front Oncol. 2022. PMID: 36353535 Free PMC article.
Prediction of Protumorigenic Effects after Image-Guided Radiofrequency Ablation of Hepatocellular Carcinoma Using Biomarkers.
Stechele M, Wildgruber M, Markezana A, Kästle S, Öcal E, Kimm MA, Alunni-Fabbroni M, Paldor M, Haixing L, Salvermoser L, Pech M, Powerski M, Galun E, Ricke J, Goldberg SN. Stechele M, et al. Among authors: wildgruber m. J Vasc Interv Radiol. 2023 Sep;34(9):1528-1537.e1. doi: 10.1016/j.jvir.2022.11.024. Epub 2022 Nov 25. J Vasc Interv Radiol. 2023. PMID: 36442741
Establishment of an interdisciplinary vascular anomalies program in Tanzania, East Africa.
Puhr-Westerheide D, Masthoff M, Shah J, Krechel A, Shemwetta M, Naif AA, Ukweh ON, Abdul Z, Sarkar A, Baraka BM, Malecela F, Lekasio PJ, Rajab L, Mungia A, Sianga W, Manji KP, Mbuguje EM, Khoncarly S, Minja FJ, Laage Gaupp FM, Wildgruber M. Puhr-Westerheide D, et al. Among authors: wildgruber m. Front Med (Lausanne). 2023 Jan 10;9:1056539. doi: 10.3389/fmed.2022.1056539. eCollection 2022. Front Med (Lausanne). 2023. PMID: 36703894 Free PMC article.
Profiling specific cell populations within the inflammatory tumor microenvironment by oscillating-gradient diffusion-weighted MRI.
Hoffmann E, Gerwing M, Niland S, Niehoff R, Masthoff M, Geyer C, Wachsmuth L, Wilken E, Höltke C, Heindel WL, Hoerr V, Schinner R, Berger P, Vogl T, Eble JA, Maus B, Helfen A, Wildgruber M, Faber C. Hoffmann E, et al. Among authors: wildgruber m. J Immunother Cancer. 2023 Mar;11(3):e006092. doi: 10.1136/jitc-2022-006092. J Immunother Cancer. 2023. PMID: 36918222 Free PMC article.
Vascular response patterns to targeted therapies in murine breast cancer models with divergent degrees of malignancy.
Hoffmann E, Gerwing M, Krähling T, Hansen U, Kronenberg K, Masthoff M, Geyer C, Höltke C, Wachsmuth L, Schinner R, Hoerr V, Heindel W, Karst U, Eisenblätter M, Maus B, Helfen A, Faber C, Wildgruber M. Hoffmann E, et al. Among authors: wildgruber m. Breast Cancer Res. 2023 May 23;25(1):56. doi: 10.1186/s13058-023-01658-9. Breast Cancer Res. 2023. PMID: 37221619 Free PMC article.
Peripheral blood-based cell signature indicates response to interstitial brachytherapy in primary liver cancer.
Kästle S, Stechele MR, Richter L, Schinner R, Öcal E, Alunni-Fabbroni M, De Toni E, Corradini S, Seidensticker M, Goldberg SN, Ricke J, Wildgruber M, Kimm MA. Kästle S, et al. Among authors: wildgruber m. J Cancer Res Clin Oncol. 2023 Sep;149(12):9777-9786. doi: 10.1007/s00432-023-04875-z. Epub 2023 May 29. J Cancer Res Clin Oncol. 2023. PMID: 37247078 Free PMC article.
Post-therapeutic microRNA-146a in liquid biopsies may determine prognosis in metastatic gastrointestinal cancer patients receiving 90Y-radioembolization.
Hirner-Eppeneder H, Öcal E, Stechele M, Öcal O, Gu S, Kimm MA, Wildgruber M, Salvermoser L, Kazmierczak P, Corradini S, Rudelius M, Piontek G, Pech M, Goldberg SN, Ricke J, Alunni-Fabbroni M. Hirner-Eppeneder H, et al. Among authors: wildgruber m. J Cancer Res Clin Oncol. 2023 Nov;149(14):13017-13026. doi: 10.1007/s00432-023-05185-0. Epub 2023 Jul 19. J Cancer Res Clin Oncol. 2023. PMID: 37466799 Free PMC article.
Circulating miR-21 as a prognostic biomarker in HCC treated by CT-guided high-dose rate brachytherapy.
Stechele M, Link H, Hirner-Eppeneder H, Alunni-Fabbroni M, Wildgruber M, Salvermoser L, Corradini S, Schinner R, Ben Khaled N, Rössler D, Galun E, Goldberg SN, Ricke J, Kazmierczak PM. Stechele M, et al. Among authors: wildgruber m. Radiat Oncol. 2023 Jul 28;18(1):125. doi: 10.1186/s13014-023-02316-2. Radiat Oncol. 2023. PMID: 37507808 Free PMC article.
Multiparametric chemical exchange saturation transfer MRI detects metabolic changes in breast cancer following immunotherapy.
Hoffmann E, Schache D, Höltke C, Soltwisch J, Niland S, Krähling T, Bergander K, Grewer M, Geyer C, Groeneweg L, Eble JA, Vogl T, Roth J, Heindel W, Maus B, Helfen A, Faber C, Wildgruber M, Gerwing M, Hoerr V. Hoffmann E, et al. Among authors: wildgruber m. J Transl Med. 2023 Aug 28;21(1):577. doi: 10.1186/s12967-023-04451-6. J Transl Med. 2023. PMID: 37641066 Free PMC article.
240 results